Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-05T15:02:30.711Z Has data issue: false hasContentIssue false
  • English
  • Français

Androgen insensitivity syndrome

Published online by Cambridge University Press:  02 March 2009

Jennifer A Batch ,
Mark N Patterson  and
Leuan A Hughes
Jennifer A Batch
Affiliation:
University of Cambridge, Addenbrooke's Hospital, Cambridge, UK
Mark N Patterson
Affiliation:
University of Cambridge, Addenbrooke's Hospital, Cambridge, UK
Leuan A Hughes*
Affiliation:
University of Cambridge, Addenbrooke's Hospital, Cambridge, UK
*
Ieuan Hughes, Professor of Paediatrics, Department of Paediatrics, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK.
Get access Rights & Permissions [Opens in a new window]

Extract

Over the past four years, major advances in the understanding of the aetiology and pathogenesis of the androgen insensitivity syndrome (AIS) have occurred. This review aims to summarize current information on clinical, diagnostic, therapeutic and molecular aspects of AIS.

Type
Articles
Information
Reproductive Medicine Review , Volume 1 , Issue 2 , July 1992 , pp. 131 - 150
Copyright
Copyright © Cambridge University Press 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Steglehner, G. De Hermaphroditism Nature. Kunz Bambergae et Lipsias, 1817.Google Scholar
2 Petterson, G, Bonnier, G. Inherited sex mosaic in man. Hereditas 1937; 23: 49–69.CrossRefGoogle Scholar
3 Morris, J. The syndrome of testicular feminisation in male pseudohermaphrodites. Am J Obstet Gynecol 1953; 65: 1192–1211.CrossRefGoogle ScholarPubMed
4 Morris, J, Mahesh, V. Further observations on the syndrome, ‘testicular feminisation’. Am J Obstet Gynecol 1963; 12: 1–13.Google Scholar
5 Griffin, J, Wilson, J. The syndromes of androgen resistance. N Engl J Med 1980; 302: 198–209.CrossRefGoogle ScholarPubMed
6 Hughes, I, Pinsky, L. Sexual differentiation. In: Collu, R, Ducharme, J, Guyda, HJ eds. Pediatric endocrinology, second edition. New York: Raven Press, 1989: 251–93.Google Scholar
7 Albright, F, Butler, A, Bloomberg, E. Rickets resistant to vitamin D. Am J Dis Child 1937; 54: 529–47.Google Scholar
8 Albright, F, Burnett, C, Smith, P, Parson, W. Pseudohypoparathyroidism – an example of the ‘seabright Bantam’ syndrome. Endocrinology 1942; 30: 922–32.Google Scholar
9 Sinclair, A, Berta, P, Palmer, M et al. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 1990; 346: 240–44.CrossRefGoogle ScholarPubMed
10 Gubbay, J, Collignon, J, Koopman, P et al. A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes. Nature 1990; 346: 245–50.CrossRefGoogle Scholar
11 Miller, W. Immunoassays for human Müllerian Inhibitory Factor (MIF): new insights into the physiology of MIF. J Clin Endocrinol Metab 1990; 70: 8–10.Google ScholarPubMed
12 Wilson, J, Griffin, J, George, F, Leshin, M. The role of gonadal steroids in sexual differentiation. Recent Prog Horm Res 1981; 37: 1–39.Google ScholarPubMed
13 Petra, P. The plasma sex steroid binding protein (SBG or SHBG). A critical review of recent developments on the structure, molecular biology and function. J Steroid Biochem Mol Biol 1991; 40: 735–53.CrossRefGoogle ScholarPubMed
14 King, R. Effects of steroid hormones and related compounds on gene transcription. Clin Endocrinol 1992; 36: 1–14.CrossRefGoogle ScholarPubMed
15 Carson-Jurica, M, Schrader, W, O'Malley, B. Steroid receptor family: structure and functions. Endocr Rev 1990; 11: 201–20.CrossRefGoogle ScholarPubMed
16 Aguirre-Ulloa, A, Mendez, J, Angeles, A, del Castillo, C, Chavez, B, Perez-Palacios, G. The presence of Müllerian remnants in the complete androgen insensitivity syndrome: a steroid hormone mediated effect? Fertil Steril 1986; 45: 302–305.CrossRefGoogle Scholar
17 Aguirre-Ulloa, A, Carranza-Lira, S, Mendez, J, Angeles, A, Chavez, B, Perez-Palacios, G. Incomplete regression of Müllerian ducts in the androgen insensitivity syndrome. Fertil Steril 1990; 53: 1024–28.CrossRefGoogle Scholar
18 Cundy, T, Rees, M, Evans, B, Hughes, I, Butler, M, Wheeler, M. Mild androgen insensitivity presenting with sexual dysfunction. Fertil Steril 1986; 46: 721–23.CrossRefGoogle ScholarPubMed
19 Aiman, J, Griffin, J. The frequency of androgen receptor deficiency in infertile men. J Clin Endocrinol Metab 1982; 54: 725–32.CrossRefGoogle ScholarPubMed
20 Bouchard, P, Wright, F, Portois, M, Couzinet, B, Schaison, G, Mowszowicz, I. Androgen insensitivity in oligospermic men: a reappraisal. J Clin Endocrinol Metab 1986; 63: 1241–46.CrossRefGoogle Scholar
21 Wilson, J, Harrod, M, Goldstein, J, Hensell, D, MacDonald, P. Familial male pseudohermaphroditism, type 1: evidence for androgen resistance and variable clinical manifestations in a family with the Reifenstein syndrome. N Engl J Med 1974; 290: 1097–1103.CrossRefGoogle Scholar
22 Judd, H, Hamilton, C, Barlow, J, Yen, S, Kliman, B. Androgen and gonadotrophin dynamics in testicular feminisation syndrome. J Clin Endocrinol Metab 1972; 34: 229–34.CrossRefGoogle Scholar
23 Tremblay, R, Kowarski, J, Park, I-J, Migeon, C. Blood production rate of dihydrotestosterone in the syndrome of male pseudohermaphroditism with testicular feminisation. J Clin Endocrinol Metab 1972; 35: 101–107.CrossRefGoogle Scholar
24 Savage, M, Chaussain, J, Evain, D, Roger, M, Canlorbe, P, Job, J. Endocrine studies in male pseudohermaphroditism in childhood and adolescence. Clin Endocrinol 1978; 8: 219–31.CrossRefGoogle ScholarPubMed
25 Zarate, A, Canales, E, Soria, J, Carballo, O. Studies on the luteinising hormone and follicle-stimulating hormone-releasing mechanism in the testicular feminisation syndrome. Am J Obstet Gynecol 1974; 119: 971–77.CrossRefGoogle Scholar
26 Faiman, C, Winter, J. The control of gonadotrophin secretion in complete testicular feminisation. J Clin Endocrinol Metab 1974; 39: 631–38.CrossRefGoogle Scholar
27 Boyar, R, Moore, R, Rosner, W et al. Studies of gonadotrophin-gonadal dynamics in patients with androgen insensitivity. J Clin Endocrinol Metab 1978; 47: 1116–22.CrossRefGoogle Scholar
28 MacDonald, P, Madden, J, Brenner, P, Wilson, J, Siiteri, P. Origin of estrogen in normal men and in women with testicular feminisation. J Clin Endocrinol Metab 1979; 49: 905–16.CrossRefGoogle Scholar
29 Kelch, R, Jenner, M, Weinstein, R, Kaplan, S, Grumbach, M. Estradiol and testosterone secretion by human, simian, and canine testes, in males with hypogonadism and in male pseudohermaphrodites with the feminising testes syndrome. J Clin Invest 1972; 51: 824–30.CrossRefGoogle Scholar
30 Cunningham, S, Loughlin, T, Culliton, M, McKenna, T. The relationship between sex steroids and sex hormone binding globulin in plasma in physiological and pathological conditions. Ann Clin Biochem 1984; 22: 489–97.CrossRefGoogle Scholar
31 Hughes, I, Evans, B. Some aspects of androgen insensitivity. Acta Endocrinol (Copenh) 1986; (suppl) 279: 386–95.Google ScholarPubMed
32 Keenan, B, Meyer, WI, Hadjian, A, Jones, H, Midgeon, C. Syndrome of androgen insensitivity in man: absence of 5α-dihydrotestosterone binding protein in skin fibroblasts. J Clin Endocrinol Metab 1974; 38: 1143–46.CrossRefGoogle ScholarPubMed
33 Hughes, I, Evans, B. The fibroblast as a model for androgen resistant states. Clin Endocrinol (Oxf) 1988;28: 565–79.CrossRefGoogle Scholar
34 Herfert, J, Wienker, T, Ropers, H. The presence of androgen-binding receptors in genital and nongenital skin fibroblasts. Hum Genet 1980; 53: 271–73.CrossRefGoogle ScholarPubMed
35 Hughes, I, Evans, B. Androgen insensitivity in forty-nine patients: classification based on clinical and androgen receptor phenotypes. Horm Res 1987; 28: 25–29.CrossRefGoogle ScholarPubMed
36 Rutgers, J, Scully, R. The androgen insensitivity syndrome (testicular feminisation): a clinicopathologic study of 43 cases. Int J Gynecol Pathol 1991; 10: 126–44.CrossRefGoogle ScholarPubMed
37 Hughes, I ed. The gonads. Handbook of endocrine investigations in children, second edition. Butterworths, Guildford: 1989: 111–12.Google Scholar
38 Andler, W, Zachmann, M. Spontaneous breast development in an adolescent with testicular feminisation after castration in early childhood. J Pediatr 1979; 94: 304–305.CrossRefGoogle Scholar
39 Scully, R. Neoplasia associated with anomalous sexual development and abnormal sex chromosomes. Pediatr Adolesc Endocr 1981; 8: 203–17.Google Scholar
40 Grino, P, Isidro-Gutierrez, R, Griffin, J, Wilson, J. Androgen resistance associated with a qualitative abnormality of the androgen receptor and responsive to high dose androgen therapy. J Clin Endocrinol Metab 1989; 68: 578–84.CrossRefGoogle ScholarPubMed
41 Price, P, Wass, J, Griffin, J et al. High dose androgen therapy in male pseudohermaphroditism due to 5α-reductase deficiency and disorders of the androgen receptor. J Clin Invest 1984; 74: 1496–1508.CrossRefGoogle Scholar
42 Pinsky, L, Kaufman, M, Killinger, D. Impaired spermatogenesis is not an obligate expression of receptor-defective androgen resistance. Am J Med Genet 1989; 32: 100–104.CrossRefGoogle Scholar
43 Duckett, J. Hypospadias repair. In: Frank, J, Johnston, J eds.Operative paediatric urology. Edinburgh: Churchill Livingstone, 1990: 197–208.Google Scholar
44 Chilvers, C, Dudley, N, Gough, M. Undescended testes: the effect of treatment on subsequent risks of subfertility and malignancy. J Pediatr Surg 1986; 21: 691–96.CrossRefGoogle ScholarPubMed
45 Giwercman, A, Brunn, E, Frimodt-Moller, C, Skakkebaek, N. Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. J Urol 1989; 142: 998–1002.CrossRefGoogle ScholarPubMed
46 Verp, M, Simpson, J. Abnormal sexual differentiation and neoplasia. Cancer Genet Cytogenet 1987; 25: 191–218.CrossRefGoogle ScholarPubMed
47 Cassio, A, Cacciari, E, D'Errico, A et al. Incidence of intratubular germ cell neoplasia in androgen insensitivity syndrome. Acta Endocrinol (Copenh) 1990;123: 416–22.Google ScholarPubMed
48 Hurt, W, Bodurtha, J, McCall, J, Moinuddin Ali, M. Seminoma in pubertal patient with androgen insensitivity syndrome. Am J Obstet Gynecol 1989; 161: 530–31.CrossRefGoogle ScholarPubMed
49 Breckenridge, R, Nash, E, Litz, J. Gonadoblastoma in male pseudohermaphroditism. Exp Med Surg 1969; 27: 330–35.Google ScholarPubMed
50 Hauser, G. Testicular feminisation. In: Overzier, C ed. Intersexuality. New York: Academic Press, 1963: 255–76.Google ScholarPubMed
51 O'Connell, M, Ramsey, H, Whang-Peng, J, Wiernik, P. Testicular feminisation syndrome in three sibs: emphasis on gonadal neoplasia. Am J Med Sci 1973; 265: 321–33.CrossRefGoogle Scholar
52 Manuel, M, Katayama, K, Jones, H. The age of occurrence of gonadal tumours in intersex patients with a Y chromosome. Am J Obstet Gynecol 1976; 124: 293–300.CrossRefGoogle ScholarPubMed
53 Khodr, G. An elderly patient with testicular feminisation. Fertil Steril 1979; 32: 708–709.CrossRefGoogle Scholar
54 O'Dowd, J, Gaffney, E, Young, R. Malignant sex-cord stromal tumour in a patient with androgen insensitivity syndrome. Histopathology 1990; 16: 279–82.CrossRefGoogle Scholar
55 Haefner, H, Terada, K, Morley, G, Davis, K. Squamous cell carcinoma of the vulva in a patient with androgen insensitivity syndrome. Gynecol Oncol 1990; 38: 132–34.CrossRefGoogle Scholar
56 Jorgensen, N, Müller, J, Giwercman, A, Skakkebaek, N. Clinical and biological significance of carcinoma in situ of the testis. Cancer Surv 1990; 9: 287–302.Google ScholarPubMed
57 Müller, J, Skakkebaek, N, Ritzen, M, Ploen, L, Petersen, K. Carcinoma in situ of the testis in children with 45X/46XY gonadal dysgenesis. J Pediatr 1985; 106: 431–36.CrossRefGoogle Scholar
58 Müller, J, Skakkebaek, N, Nielsen, O, Graem, N. Cryptorchidism and testis cancer: atypical infantile germ cells followed by carcinoma in situ and invasive carcinoma in adulthood. Cancer 1984; 54: 629–34.3.0.CO;2-E>CrossRefGoogle ScholarPubMed
59 Müller, J, Skakkebaek, N. Testicular carcinoma in situ in children with the androgen insensitivity (testicular feminisation) syndrome. Br Med J 1984; 288: 1419–20.CrossRefGoogle ScholarPubMed
60 Müller, J. Abnormal infantile germ cells and development of carcinoma in situ in maldeveloped testes. A stereological and densitometric study. Int J Androl 1987; 10: 543–67.CrossRefGoogle ScholarPubMed
61 Giwercman, A, von der Maase, H, Berthelsen, J, Rorth, M, Bertelsen, A, Skakkebaek, N. Localised irradiation of testes with carcinoma in situ: effects on Leydig cell function and eradication of malignant cells in 20 patients. J Clin Endocrinol Metab 1991; 73: 596–603.CrossRefGoogle ScholarPubMed
62 Larrea, F, Benavides, G, Scaglia, H et al. Gynecomastia as a familial incomplete pseudohermaphroditism, type 1: a limited androgen resistance syndrome. J Clin Endocrinol Metab 1978; 46: 961–70.CrossRefGoogle ScholarPubMed
63 Grino, P, Griffin, J, Cushard, W, Wilson, J. A mutation of the androgen receptor associated with partial androgen resistance, familial gynecomastia and fertility. J Clin Endocrinol Metab 1988; 66: 754–61.CrossRefGoogle ScholarPubMed
64 Ludwig, G, Potempa, J. Der optimale Zeitpunkt der behandlung des Kryptorchismus. Dtsch Med Wochenschr 1975; 100: 680.CrossRefGoogle Scholar
65 Aiman, J, Griffin, J, Gazak, J, Wilson, J, MacDonald, P. Androgen insensitivity as a cause of infertility in otherwise normal men. N Engl J Med 1979; 300: 223–27.CrossRefGoogle ScholarPubMed
66 Morrow, A, Gyorki, S, Warne, G et al. Variable androgen receptor levels in infertile men. J Clin Endocrinol Metab 1987; 64: 1115–21.CrossRefGoogle ScholarPubMed
67 Gooren, L. Improvement of spermatogenesis after treatment with the anti-oestrogen tamoxifen in a man with the incomplete androgen insensitivity syndrome. J Clin Endocrinol Metab 1989; 68: 1207–10.CrossRefGoogle Scholar
68 Lubahn, D, Joseph, D, Sullivan, P, Willard, H, French, F, Wilson, E. Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 1988; 240: 327–30.CrossRefGoogle ScholarPubMed
69 Chang, C, Kokontis, J, Liao, S. Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 1988; 240: 324–26.CrossRefGoogle ScholarPubMed
70 Chang, C, Kokontis, J, Liao, S. Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Natl Acad Sci USA 1988; 85: 7211–15.CrossRefGoogle ScholarPubMed
71 Lubahn, D, Joseph, D, Sar, M et al. The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol 1988; 2: 1265–75.CrossRefGoogle ScholarPubMed
72 Tilley, W, Marcelli, M, Wilson, J, McPhaul, M. Characterization and expression of a cDNA encoding the human androgen receptor. Proc Natl Acad Sci USA 1989; 86: 327–31.CrossRefGoogle ScholarPubMed
73 Trapman, J, Klaasen, P, Kuiper, G et al. Cloning, structure and expression of a cDNA encoding the human androgen receptor. Biochem Biophys Res Commun 1988; 153: 241–48.CrossRefGoogle ScholarPubMed
74 Faber, P, Kuiper, G, van Rooij, H, van der Korput, J, Brinkmann, A, Trapman, J. The N-terminal domain of the human androgen receptor is encoded by one large exon. Mol Cell Endocrinol 1989; 61: 257–62.CrossRefGoogle ScholarPubMed
75 Brown, C, Goss, S, Lubahn, D et al. Androgen receptor locus on the human X chromosome: regional localization to Xq11–12 and description of a DNA polymorphism. Am J Hum Genet 1989; 44: 264–69.Google ScholarPubMed
76 Kuiper, G, Faber, P, van Rooij, H et al. Structural organization of the human androgen receptor gene. J Mol Endocrinol 1989; 2: R1–R4.CrossRefGoogle ScholarPubMed
77 Schwabe, J, Rhodes, D. Beyond zinc fingers: steroid hormone receptors have a novel structural motif for DNA recognition. Trends Biochem Sci 1991; 16: 291–96.CrossRefGoogle ScholarPubMed
78 Fawell, S, Lees, J, White, R, Parker, M. Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell 1990; 60: 953–62.CrossRefGoogle ScholarPubMed
79 Simental, J, Sar, M, Lane, M, French, F, Wilson, E. Transcriptional activation and nuclear targeting signals of the human androgen receptor. J Biol Chem 1991; 266: 510–18.CrossRefGoogle ScholarPubMed
80 Jenster, G, van der Korput, H, van Vroonhoven, C, van der Kwast, T, Trapman, J, Brinkmann, A. Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol Endocrinol 1991; 5: 1396–1404.CrossRefGoogle ScholarPubMed
81 Sambrook, J, Fritsch, E, Maniatis, T. Expression of cloned genes in cultured mammalian cells. In: Molecular cloning, second edition. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989:16. 1–16.31.Google Scholar
82 Chang, C, Whelan, C, Popovich, T, Kokontis, J, Liao, S. Fusion proteins containing androgen receptor sequences and their use in the production of poly-and monoclonal anti-androgen receptor antibodies. Endocrinology 1989; 125: 1097–99.CrossRefGoogle ScholarPubMed
83 Husmann, D, Wilson, C, McPhaul, M, Tilley, W, Wilson, J. Antipeptide antibodies to two distinct regions of the androgen receptor localise the receptor protein to the nuclei of target cells in the rat and human prostate. Endocrinology 1990; 126: 2359–68.CrossRefGoogle Scholar
84 Sar, M, Lubahn, D, French, F, Wilson, E. Immunohistochemical localization of the androgen receptor in rat and human tissues. Endocrinology 1990;127: 3180–86.CrossRefGoogle ScholarPubMed
85 van Laar, J, Voorhorst-Ogink, M, Zegers, N et al. Characterisation of polyclonal antibodies against the N-terminal domain of the human androgen receptor. Mol Cell Endocrinol 1989; 67: 29–38.CrossRefGoogle ScholarPubMed
86 French, F, Lubahn, D, Brown, T et al. Molecular basis of androgen insensitivity. Recent Prog Horm Res 1991;46: 1–42.Google Scholar
87 Takeda, H, Chodak, G, Mutchnik, S, Nakamoto, T, Chang, C. Immunohistochemical localization of androgen receptors with mono-and polyclonal antibodies to androgen receptor. J Endocrinol 1990; 126: 17–25.CrossRefGoogle ScholarPubMed
88 Brown, T, Lubahn, D, Wilson, E, Joseph, D, French, F, Migeon, C. Deletion of the steroid binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: evidence for further genetic heterogeneity in this syndrome. Proc Natl Acad Sci USA 1988; 85: 8151–55.CrossRefGoogle ScholarPubMed
89 Trifiro, M, Gottlieb, B, Pinsky, L et al. The 56/58 kDa androgen-binding protein in male genital skin fibroblasts with a deleted androgen receptor gene. Mol Cell Endocrinol 1991; 75: 37–47.CrossRefGoogle ScholarPubMed
90 Quigley, C, Friedman, K, Johnson, A et al. Complete deletion of the androgen receptor: definition of the null phenotype of the androgen insensitivity syndrome and determination of carrier status. J Clin Endocrinol Metab 1992; 74: 927–33.CrossRefGoogle ScholarPubMed
91 Quigley, C, Evans, B, Simental, J et al. Complete androgen insensitivity due to deletion of exon C of the androgen receptor gene reveals the functional importance of the second zinc finger of the androgen receptor in vivo. Mol Endocrinol 1992 (in press).CrossRefGoogle Scholar
92 Hughes, I, Evans, B. Complete androgen insensitivity syndrome characterized by increased concentration of a normal androgen receptor in genital skin fibroblasts. J Clin Endocrinol Metab 1986; 63: 309–15.CrossRefGoogle ScholarPubMed
93 Evans, B, Ismail, R, France, T, Hughes, I. Analysis of the androgen receptor gene structure in a patient with complete androgen insensitivity syndrome. J Endocrinol 1991; 129: (suppl): abstract 65.Google Scholar
94 Ris-Stalpers, C, Kuiper, G, Faber, P et al. Abberant splicing of androgen receptor mRNA results in synthesis of a nonfunctional receptor protein in a patient with androgen insensitivity. Proc Natl Acad Sci USA 1990; 87: 7866–70.CrossRefGoogle Scholar
95 Marcelli, M, Tilley, W, Wilson, C, Griffin, J, Wilson, J, McPhaul, M. Definition of the human androgen receptor gene structure permits the identification of mutations that cause androgen resistance: premature termination of the receptor protein at amino acid residue 588 causes complete androgen resistance. Mol Endocrinol 1990; 4: 1105–16.CrossRefGoogle ScholarPubMed
96 Sai, T, Seino, S, Chang, C et al. An exonic point mutation of the androgen receptor gene in a family with complete androgen insensitivity. Am J Hum Genet 1990; 46: 1095–1100.Google Scholar
97 Marcelli, M, Tilley, W, Wilson, C, Wilson, J, Griffin, J, McPhaul, M. A single nucleotide substitution introduces a premature termination codon into the androgen receptor gene of a patient with receptor-negative androgen resistance. J Clin Invest 1990; 85: 1522–28.CrossRefGoogle ScholarPubMed
98 de Bellis, A, Quigley, C, Cartello, N, Ho, K, French, F. DNA and steroid binding domain mutations of the androgen receptor cause partial or complete androgen insensitivity. 73rd Annual Meeting of The Endocrine Society, Washington DC, 1991: 316 (abstract 1141).Google Scholar
99 Trifiro, M, Prior, R, Sabbaghian, N et al. Amber mutation creates a diagnostic Mael site in the androgen receptor gene of a family with complete androgen insensitivity. Am J Med Genet 1991; 40: 493–99.CrossRefGoogle Scholar
100 Zoppi, S, Marcelli, M, Griffin, J, Wilson, J. Point mutations in the DNA-binding domain are a frequent cause of receptor-positive androgen resistance. 73rd Annual Meeting of The Endocrine Society, Washington DC, 1991: 94 (abstract 254).Google Scholar
101 Chang, Y, Migeon, C, Brown, T. Human androgen insensitivity syndrome due to androgen receptor gene point mutations in subjects with normal androgen receptor levels but impaired biological activity. 73rd Annual Meeting of The Endocrine Society, Washington DC, 1991: 37 (abstract 28).Google Scholar
102 Evans, B. (Personal communication, 1992).Google Scholar
103 Marcelli, M, Zoppi, S, Orino, P, Griffin, J, Wilson, J, McPhaul, M. A mutation in the DNA-binding domain of the androgen receptor gene causes complete testicular feminization in a patient with receptor-positive androgen resistance. J Clin Invest 1991; 87:1123–26.CrossRefGoogle Scholar
104 Ris-Stalpers, C, Trifiro, M, Kuiper, G et al. Substitution of aspartic acid-686 by histidine or asparagine in the human androgen receptor leads to a functionally inactive protein with altered hormone-binding characteristics. Mol Endocrinol 1991; 5: 1562–69.CrossRefGoogle ScholarPubMed
105 McPhaul, M, Marcelli, M, Tilley, W, Griffin, J, Isidro-Guitierrez, R, Wilson, J. Molecular basis of androgen resistance in a family with qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy. J Clin Invest 1991; 87: 1413–21.CrossRefGoogle Scholar
106 Trifiro, M, Prior, L, Pinksy, L et al. A single transition at an exonic CpG site apparently abolishes androgen receptor (AR)-binding activity in a family with complete androgen insensitivity (CAI). Am J Hum Genet 1989; 45 (suppl): A225.Google Scholar
107 Marcelli, M, Tilley, W, Zoppi, S, Griffin, J, Wilson, J, McPhaul, M. Androgen resistance associated with a mutation of the androgen receptor at amino acid 772 (arg→cys) results from a combination of decreased messenger ribonucleic acid levels and impairment of receptor function. J Clin Endocrinol Metab 1991; 73: 318–25.CrossRefGoogle ScholarPubMed
108 Brown, T, Lubahn, D, Wilson, E, French, F, Migeon, C, Corden, J. Functional characterisation of naturally occurring mutant androgen receptors from patients with complete androgen insensitivity. Mol Endocrinol 1990; 4:1759–72.CrossRefGoogle Scholar
109 Batch, J, Evans, B, Hughes, I, Patterson, M. Mutations of the androgen receptor gene identified in permeai hypospadias [Unpublished observations].Google Scholar
110 Batch, J, Williams, D, Davies, H et al. Androgen receptor gene mutations identified by SSCP in fourteen subjects with androgen insensitivity syndrome [Unpublished observations].Google Scholar
111 Lubahn, D, Brown, T, Simental, J et al. Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc Natl Acad Sci USA 1989; 86: 9534–38.CrossRefGoogle Scholar
112 Yarbrough, W, Quarmby, V, Simental, J et al. A single base mutation in the androgen receptor gene causes androgen insensitivity in the testicular feminized rat. J Biol Chem 1990; 265: 8893–8900.CrossRefGoogle ScholarPubMed
113 Charest, N, Zhou, Z-X, Lubahn, D, Olsen, K, Wilson, E, French, F. A frame-shift mutation destabilizes androgen receptor messenger RNA in the Tfm mouse. Mol Endocrinol 1991; 5: 573–81.CrossRefGoogle ScholarPubMed
114 Mitchell, P, Tjian, R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 1989; 245: 371–78.CrossRefGoogle ScholarPubMed
115 He, W, Kumar, M, Tindall, D. A frame-shift mutation in the androgen receptor gene causes complete androgen insensitivity in the testicular feminized mouse. Nucleic Acids Res 1991; 19: 2373–78.CrossRefGoogle ScholarPubMed
116 La Spada, A, Wilson, E, Lubahn, D, Harding, A, Fischbeck, K. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991; 352: 77–79.CrossRefGoogle ScholarPubMed
117 Harding, A, Thomas, P, Baraitser, M, Bradbury, P, Morgan-Hughes, J, Ponsford, J. X-linked recessive bulbospinal neuronopathy: a report of ten cases. J Neural Neurosurg Psychiatry 1982; 45: 1012–19.CrossRefGoogle ScholarPubMed
118 Call, K, Glaser, T, Ito, C et al. Isolation and characterisation of a zinc finger polypeptide gene at the human chromosome 11 Wilm's tumor locus. Cell 1990; 60: 509–20.CrossRefGoogle ScholarPubMed
119 Gessler, M, Poustka, A, Cavenee, W, Neve, R, Orkin, S, Bruns, G. Homozygous deletion in Wilm's tumor of a zinc finger gene identified by chromosome jumping. Nature 1990; 343: 774–78.CrossRefGoogle ScholarPubMed
120 Pritchard-Jones, K, Fleming, S, Davidson, D et al. The candidate Wilm's tumor gene is involved in genitourinary development. Nature 1990; 346: 194–97.CrossRefGoogle ScholarPubMed
121 van Heyningen, V, Bickmore, W, Seawright, A et al. Role for the Wilm's tumour gene in genital development. Proc Natl Acad Sci USA 1990; 87: 5383–86.CrossRefGoogle ScholarPubMed
122 Pelletier, J, Bruening, W, Kashtan, C et al. Germline mutations in the Wilm's tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991; 67: 437–47.CrossRefGoogle ScholarPubMed
123 Power, R, Mani, S, Codina, J, Conneely, O, O'Malley, B. Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 1991; 254: 1636–39.CrossRefGoogle ScholarPubMed